<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font15 { font-size : 15; } .font16 { font-size : 16; } .font17 { font-size : 17; } .font19 { font-size : 19; } .font21 { font-size : 21; } .font22 { font-size : 22; } .font23 { font-size : 23; } .font24 { font-size : 24; } .font27 { font-size : 27; } .font30 { font-size : 30; } .font31 { font-size : 31; }</style>
 <body>
  <p>
   <span class="font31">treatment </span>
   <span class="font31">(.) </span>
   <span class="font30">ART </span>
   <span class="font27">patients </span>
   <span class="font24">HIV </span>
   <span class="font23">eligible </span>
   <span class="font23">initiation </span>
   <span class="font22">stage </span>
   <span class="font22">count </span>
   <span class="font22">eligibility </span>
   <span class="font21">[.–.] </span>
   <span class="font21">[.;.] </span>
   <span class="font19">care </span>
   <span class="font19">clinical </span>
   <span class="font17">entry </span>
   <span class="font16">time </span>
   <span class="font16">{border-style </span>
   <span class="font16">period </span>
   <span class="font16">[–] </span>
   <span class="font16">data </span>
   <span class="font16">people </span>
   <span class="font16">px;} </span>
   <span class="font15">#ffffff;} </span>
   <span class="font15">[]. </span>
   <span class="font15">proportion </span>
   <span class="font15">study </span>
   <span class="font15">regardless </span>
   <span class="font15">(%) </span>
   <span class="font15">months </span>
   <span class="font15">visits </span>
   <span class="font14">&amp;lt; </span>
   <span class="font14">Sciences </span>
   <span class="font14">median </span>
   <span class="font14">patient </span>
   <span class="font14">years </span>
   <span class="font14">Health </span>
   <span class="font14">Period </span>
   <span class="font14">analysis </span>
   <span class="font14">antiretroviral </span>
   <span class="font14">cells/mm </span>
   <span class="font14">Pathogens </span>
   <span class="font14">follow-up </span>
   <span class="font14">observed </span>
   <span class="font14">population </span>
   <span class="font13">Senegal </span>
   <span class="font13">increased </span>
   <span class="font13">medical </span>
   <span class="font13">periods </span>
   <span class="font13">started </span>
   <span class="font13">Antiretroviral </span>
   <span class="font13">Medicine </span>
   <span class="font13">according </span>
   <span class="font13">criteria </span>
   <span class="font13">review </span>
   <span class="font13">Biology </span>
   <span class="font13">did </span>
   <span class="font12">Dakar, </span>
   <span class="font12">Life </span>
   <span class="font12">World </span>
   <span class="font12">advanced </span>
   <span class="font12">age </span>
   <span class="font12">center </span>
   <span class="font12">countries </span>
   <span class="font12">delay </span>
   <span class="font12">expansions </span>
   <span class="font12">likely </span>
   <span class="font12">number </span>
   <span class="font12">patients, </span>
   <span class="font12">px; </span>
   <span class="font12">significant </span>
   <span class="font12">therapy </span>
   <span class="font12">treated </span>
   <span class="font12">{font-family </span>
   <span class="font12">AIDS </span>
   <span class="font12">CTA </span>
   <span class="font12">ESOPE </span>
   <span class="font12">Therapy </span>
   <span class="font12">Viral </span>
   <span class="font12">access </span>
   <span class="font12">collab: </span>
   <span class="font12">defined </span>
   <span class="font12">font-size </span>
   <span class="font12">increase </span>
   <span class="font12">initiating </span>
   <span class="font12">period, </span>
   <span class="font12">sex </span>
   <span class="font12">used </span>
   <span class="font12">.*** </span>
   <span class="font12">Dakar </span>
   <span class="font12">Infect </span>
   <span class="font12">Median </span>
   <span class="font12">Microbiology </span>
   <span class="font12">account </span>
   <span class="font12">associated </span>
   <span class="font12">attending </span>
   <span class="font12">double; </span>
   <span class="font12">files </span>
   <span class="font12">free </span>
   <span class="font12">guidelines </span>
   <span class="font12">high </span>
   <span class="font12">new </span>
   <span class="font12">prior </span>
   <span class="font12">recommendations </span>
   <span class="font12">start </span>
   <span class="font12">time. </span>
   <span class="font12">visit </span>
   <span class="font11">%*** </span>
   <span class="font11">ART-naïve </span>
   <span class="font11">ART. </span>
   <span class="font11">Antiretrovirals </span>
   <span class="font11">Eligible </span>
   <span class="font11">Fann </span>
   <span class="font11">Immunodeficiency </span>
   <span class="font11">Microbial </span>
   <span class="font11">National </span>
   <span class="font11">Senegal, </span>
   <span class="font11">based </span>
   <span class="font11">border-color </span>
   <span class="font11">border-width </span>
   <span class="font11">contre </span>
   <span class="font11">counts </span>
   <span class="font11">date </span>
   <span class="font11">decreased </span>
   <span class="font11">diagnosis </span>
   <span class="font11">disease </span>
   <span class="font11">financial </span>
   <span class="font11">health </span>
   <span class="font11">increases </span>
   <span class="font11">initiated </span>
   <span class="font11">key </span>
   <span class="font11">living </span>
   <span class="font11">men </span>
   <span class="font11">naïve </span>
   <span class="font11">period. </span>
   <span class="font11">periods. </span>
   <span class="font11">pre-ART </span>
   <span class="font11">recorded </span>
   <span class="font11">results </span>
   <span class="font11">retrospective </span>
   <span class="font11">showed </span>
   <span class="font11">single </span>
   <span class="font11">solid; </span>
   <span class="font11">testing </span>
   <span class="font11">timely </span>
   <span class="font11">{font-style </span>
   <span class="font11">{font-weight </span>
   <span class="font11">(CD </span>
   <span class="font11">(Table </span>
   <span class="font11">(WHO </span>
   <span class="font11">(at </span>
   <span class="font11">.** </span>
   <span class="font11">./journal.pone..tTable </span>
   <span class="font11">ART, </span>
   <span class="font11">ART—patients </span>
   <span class="font11">Africa: </span>
   <span class="font11">CD&amp;lt; </span>
   <span class="font11">CD≥ </span>
   <span class="font11">Clin </span>
   <span class="font11">Delay </span>
   <span class="font11">Lentivirus: </span>
   <span class="font11">Lutte </span>
   <span class="font11">Occupation </span>
   <span class="font11">Organisms </span>
   <span class="font11">Patients </span>
   <span class="font11">Periods </span>
   <span class="font11">Population </span>
   <span class="font11">Retroviruses </span>
   <span class="font11">Senegal. </span>
   <span class="font11">Therapy: </span>
   <span class="font11">Treatment </span>
   <span class="font11">Viruses </span>
   <span class="font11">Viruses: </span>
   <span class="font11">[IQR], </span>
   <span class="font11">[PMC </span>
   <span class="font11">aHR </span>
   <span class="font11">analyzed </span>
   <span class="font11">article] </span>
   <span class="font11">bold </span>
   <span class="font11">cases </span>
   <span class="font11">changes </span>
   <span class="font11">characteristics </span>
   <span class="font11">compared </span>
   <span class="font11">computerized </span>
   <span class="font11">countries. </span>
   <span class="font11">courier; </span>
   <span class="font11">database </span>
   <span class="font11">decrease </span>
   <span class="font11">drugs </span>
   <span class="font11">easily </span>
   <span class="font11">eligibility, </span>
   <span class="font11">eligibility. </span>
   <span class="font11">em; </span>
   <span class="font11">entry. </span>
   <span class="font11">file </span>
   <span class="font11">group </span>
   <span class="font11">improvement </span>
   <span class="font11">including </span>
   <span class="font11">infected </span>
   <span class="font11">latest </span>
   <span class="font11">linkage </span>
   <span class="font11">management </span>
   <span class="font11">missing </span>
   <span class="font11">outpatient </span>
   <span class="font11">present </span>
   <span class="font11">process </span>
   <span class="font11">pt;} </span>
   <span class="font11">public </span>
   <span class="font11">rate </span>
   <span class="font11">reduction </span>
   <span class="font11">referral </span>
   <span class="font11">regions </span>
   <span class="font11">remained </span>
   <span class="font11">status </span>
   <span class="font11">sub-Saharan </span>
   <span class="font11">subjects. </span>
   <span class="font11">target </span>
   <span class="font11">terms </span>
   <span class="font11">therapeutic </span>
   <span class="font11">treatment, </span>
   <span class="font11">using </span>
   <span class="font11">young </span>
  </p>
 </body>
</html>
